Andrew Hendifar, MD
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute · Cedars-Sinai Medical Center · Cedars-Sinai
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrew Hendifar, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:15 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05766748 · Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic CancerCantex Pharmaceuticals · unknown · Metastatic Pancreatic Cancer · principal investigator
- Early Ph1NCT05336266 · A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal AdenocarcinomaAndrew Hendifar, MD · active not recruiting · Pancreas Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer · principal investigator
- N/ANCT05078775 · Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic CancerFaeth Therapeutics · completed · Metastatic Pancreatic Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma · principal investigator
- Ph2NCT04798781 · Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular CarcinomaAndrew Hendifar, MD · completed · Gastric Cancer, Hepatocellular Carcinoma · principal investigator
- Ph2NCT04098237 · Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic InsufficiencyAndrew Hendifar, MD · active not recruiting · Pancreatic Adenocarcinoma · principal investigator
- N/ANCT04034745 · Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/GainAndrew Hendifar, MD · withdrawn · Pancreatic Cancer, Neuroendocrine Tumors, Cachexia; Cancer · principal investigator
- Ph1NCT03207724 · Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With CachexiaAndrew Hendifar, MD · completed · Pancreatic Cancer, Cachexia, Weight Loss · principal investigator
- N/ANCT02400398 · Evaluating Weight Stability of Pancreatic Cancer Cachexia PatientsAndrew Hendifar, MD · completed · Pancreatic Neoplasms, Pancreatic Cancer, Cachexia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.